GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,000 | -54.5% | 15,100 | -34.6% | 0.00% | – |
| Q2 2016 | $11,000 | -64.5% | 23,100 | 0.0% | 0.00% | – |
| Q1 2016 | $31,000 | -27.9% | 23,100 | -20.6% | 0.00% | – |
| Q4 2015 | $43,000 | -38.6% | 29,100 | -34.8% | 0.00% | -100.0% |
| Q3 2015 | $70,000 | +159.3% | 44,600 | +185.9% | 0.00% | – |
| Q2 2015 | $27,000 | +42.1% | 15,600 | +11.4% | 0.00% | – |
| Q1 2015 | $19,000 | +18.8% | 14,000 | +33.3% | 0.00% | – |
| Q4 2014 | $16,000 | -27.3% | 10,500 | 0.0% | 0.00% | – |
| Q3 2014 | $22,000 | -31.2% | 10,500 | -0.7% | 0.00% | – |
| Q2 2014 | $32,000 | +23.1% | 10,570 | +3.6% | 0.00% | – |
| Q1 2014 | $26,000 | -66.7% | 10,200 | -35.4% | 0.00% | -100.0% |
| Q4 2013 | $78,000 | +271.4% | 15,780 | +70.0% | 0.00% | – |
| Q3 2013 | $21,000 | +600.0% | 9,280 | +625.0% | 0.00% | – |
| Q2 2013 | $3,000 | – | 1,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
| Perceptive Advisors | 200,000 | $302,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
| EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
| Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |